142 related articles for article (PubMed ID: 15741767)
1. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma.
Shibata K; Kikkawa F; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
Tumour Biol; 2005; 26(1):9-16. PubMed ID: 15741767
[TBL] [Abstract][Full Text] [Related]
2. Expression of placental leucine aminopeptidase is associated with a poor outcome in endometrial endometrioid adenocarcinoma.
Shibata K; Kikkawa F; Suzuki Y; Mizokami Y; Kajiyama H; Ino K; Nomura S; Nagasaka T; Mizutani S
Oncology; 2004; 66(4):288-95. PubMed ID: 15218296
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system.
Watanabe Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Hattori A; Tsujimoto M; Mizutani S
Clin Cancer Res; 2003 Dec; 9(17):6497-503. PubMed ID: 14695154
[TBL] [Abstract][Full Text] [Related]
4. Expression of adipocyte-derived leucine aminopeptidase in endometrial cancer. Association with tumor grade and CA-125.
Kazeto H; Nomura S; Ito N; Ito T; Watanabe Y; Kajiyama H; Shibata K; Ino K; Tamakoshi K; Hattori A; Kikkawa F; Nagasaka T; Tsujimoto M; Mizutani S
Tumour Biol; 2003; 24(4):203-8. PubMed ID: 14654715
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
[TBL] [Abstract][Full Text] [Related]
7. Localization of angiotensin II, the AT1 receptor, angiotensin-converting enzyme, aminopeptidase A, adipocyte-derived leucine aminopeptidase, and vascular endothelial growth factor in the human ovary throughout the menstrual cycle.
Harata T; Ando H; Iwase A; Nagasaka T; Mizutani S; Kikkawa F
Fertil Steril; 2006 Aug; 86(2):433-9. PubMed ID: 16769060
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
9. Expression of aquaporin-1 in normal, hyperplasic, and carcinomatous endometria.
Pan H; Sun CC; Zhou CY; Huang HF
Int J Gynaecol Obstet; 2008 Jun; 101(3):239-44. PubMed ID: 18313673
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA
J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.
Dobrzycka B; Terlikowski SJ; Kwiatkowski M; Garbowicz M; Kinalski M; Chyczewski L
Ginekol Pol; 2010 Jun; 81(6):422-5. PubMed ID: 20695190
[TBL] [Abstract][Full Text] [Related]
13. Correlation of mast cell density, tumor angiogenesis, and clinical outcomes in patients with endometrioid endometrial cancer.
Pansrikaew P; Cheewakriangkrai C; Taweevisit M; Khunamornpong S; Siriaunkgul S
Asian Pac J Cancer Prev; 2010; 11(2):309-12. PubMed ID: 20843106
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival.
Ino K; Shibata K; Kajiyama H; Yamamoto E; Nagasaka T; Nawa A; Nomura S; Kikkawa F
Br J Cancer; 2006 Feb; 94(4):552-60. PubMed ID: 16434990
[TBL] [Abstract][Full Text] [Related]
15. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma.
Hirai M; Nakagawara A; Oosaki T; Hayashi Y; Hirono M; Yoshihara T
Gynecol Oncol; 2001 Feb; 80(2):181-8. PubMed ID: 11161857
[TBL] [Abstract][Full Text] [Related]
17. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
18. Endoglin (CD105) expression in endometrial carcinoma.
Saad RS; Jasnosz KM; Tung MY; Silverman JF
Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Arafat HA; Gong Q; Chipitsyna G; Rizvi A; Saa CT; Yeo CJ
J Am Coll Surg; 2007 May; 204(5):996-1005; discussion 1005-6. PubMed ID: 17481528
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
